Quantitative methods in pharmacovigilance: Focus on signal detection

Drug Safety

Volumn 26, Issue 3, 2003, Pages 159-186

  Hauben, Manfred ^a,b,c   Zhou, Xiaofeng ^a  

^a PFIZER INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; AUTOMATION; BAYES THEOREM; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; NERVE CELL NETWORK; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL DETECTION; STATISTICAL ANALYSIS; TECHNIQUE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AUTOMATIC DATA PROCESSING; BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC METHODS; HUMANS; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; SENSITIVITY AND SPECIFICITY;

EID: 0037221866     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326030-00003     Document Type: Review

References (36)

1. Meyboom RHB, Egberts ACG, Edwards IR, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16 (6): 355-65
2. Waller PC, Lee EH. Responding to drug safety issues. Pharmacoepidemiol Drug Saf 1999; 8: 535-52
3. Lindquist M, Stahl M, Bate A, et al. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO database. Drug Saf 2000; 23 (6): 533-42
4. Kaufman DW, Rosenberg L, Mitchell A. Signal generation and clarification: use of case-control data. Pharmacoepidemiol Drug Saf 2001; 10: 197-203
5. Evans SJW. Pharmacovigilance: a science or fielding emergencies? Stat Med 2000; 19: 3199-209
6. Lindquist M, Edwards IR, Bate A, et al. From association to alert: a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999; 8: S15-25
7. Evans SJW, Waller P, Davis S. Proportional reporting ratios: the use of epidemiological methods for signal detection [abstract]. Pharmacoepidemiol Drug Saf 1998; 7 Suppl. 2: S102
8. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-6
9. Heeley EL, Wilton LV, Shakir SAW. The use of proportional reporting rations for signal generation in prescription event monitoring [abstract]. Pharmacoepidemiol Drug Saf 2002; 10 (S1): S48
10. Kilgour-Christie J, Czarnecki A, Simmons V. Proportional reporting ratio calculations from a pharmaceutical company database [abstract]. Pharmacoepidemiol Drug Saf 2001; 10: S159
11. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999; 53 (3): 177-90
12. O'Neill RT, Szarfman A. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system [discussion]. Am Stat 1999; 53 (3): 190-5
13. Louis TA, Shen W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system [discussion]. Am Stat 1999; 53 (3): 196-8
14. Madigan D. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system [discussion]. Am Stat 1999; 53 (3): 198-200
15. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system [reply]. Am Stat 1999; 53 (3): 201-2
16. Praus M, Schindel F, Fescharek R, et al. Alert systems for post-marketing surveillance of adverse drug reactions. Stat Med 1993; 12: 2383-93
17. Shore DL, Quade D. A surveillance system based on a short memory scheme. Stat Med 1989; 8: 311-22
18. Norwood PK, Sampson AR. A statistical methodology for post-marketing surveillance of adverse drug reaction reports. Stat Med 1988; 7: 1023-30
19. Parker RA. Analysis of surveillance data with Poisson regression: a case study. Stat Med 1989; 8: 285-94
20. Tubert P, Begaud B, Haramhuru F, et al. Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol 1991; 32: 407-8
21. Schroeder DR. Detecting a rare adverse drug reaction using spontaneous reports [statistics]. Reg Anesth Pain Med 1998; 2: 183-9
22. Purcell P, Barty S. Statistical techniques for signal generation: the Australian experience. Drug Saf 2002; 25 (6): 415-21
23. Heeley E, Wilton L, Shakir A. Automated signal generation in prescription event monitoring. Drug Saf 2002; 25 (6): 423-32
24. Evans S. Statistical and epidemiological principles in detecting signals of adverse drug reactions. Drug Information Association 38th Annual Meeting: 2002 Jun 16-20: Chicago (IL)
25. Code of Federal Regulations (CFR). Parts 310, 314, and 600 [online]. Available from URL: www.access.gpo.gov/cgi-hin/cfrassemble.cgi?title=200221 [Accessed 2003 Jan 28]
26. Clark JA, Berk RH, Klincewitz SL. Calculation of the probability of multiplicities in two cell-occupancy models: implications for spontaneous reporting systems. Drug Inf J 1999; 33: 1195-203
27. Begaud B, Moride Y, Tubert-Bitter P, et al. False positives in spontaneous reporting: should we worry about them? Br J Clin Pharmacol 1994; 38: 401-4
28. Kwong K, Sammon J, Hornbuckle K, et al. A novel method for detecting potential drug-drug interactions using post-marketing adverse event database [abstract]. Pharmacoepidemiol Drug Saf 2001; 10 (S1): S39
29. O'Neill RT, Szarfman A. Some US Food and Drug Administration perspectives on data mining for pediatric safety assessment. Curr Ther Res Clin Exp 2001; 62: 650-63
30. A new strategy for detection of signals in the WHO database 2002. Uppsala Reports 2001 Nov; 17: 8-9
31. Szarfman A, Machado GS, O'Neill RT. Screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in FDA's spontaneous reports database. Drug Saf 2002; 25 (6): 381-92
32. Thakrar BT, Blesch KS, Sacks ST, et al. On technical methods of signal detection [abstract]. Pharmacoepidemiol Drug Saf 2001; 10 (S1): S98
33. Van Puijenbroek E, Bate A, Leufkens H, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10
34. Coulter DM, Bate A, Meyboom R, et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ 2001; 232: 1207-9
35. Bate A, Lindquist M, Edwards IR. Pattern recognition using a recurrent neural network and its application to the WHO database [abstract]. 17th International Society for Pharmacoepidemiology: 2001 Aug 23-26; Toronto, Canada
36. DuMouchel W, Pregihon D. Empirical Bayes screening for multi-item associations. Proc. KDD. San Diego (CA): ACM Press, 2001